Top compounds associated with response to TPSD1


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC 0.076 0.02
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.076 0.02
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.02
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.081 0.02
mRNA regorafenib CTRPv2 pan-cancer AAC 0.082 0.02
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.078 0.03
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.03
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.077 0.03
mRNA phenformin GDSC1000 pan-cancer AAC 0.067 0.03
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.077 0.03
Download CSV